New side effects for Pfizer and Moderna vaccines ? At least, that's what theEuropean Medicines Agency announced this Wednesday, August 11, 2021. The two main vaccines available in Europe and France are said to be potentially the cause of three rare conditions recorded in people who have received one or more injections against Covid-19.
In a press release, theEuropean Medicines Agency explains that its services are currently studying three rare infections -erythema multiforme, glomerulonephritis and nephrotic syndrome - observed in vaccinated patients. The aim is to determine whether these symptoms are due to side-effects of the vaccines developed by Pfizer and Moderna.
What are the characteristics of these rare infections, which could be new side effects of Pfizer and Moderna vaccines? Firstly, erythema multiforme, an allergic skin reaction characterized by the appearance of red, raised, concentric skin patches. Then there's glomerulonephritis, a hard-to-pronounce term that designates kidney dysfunction, notably the formation of glomeruli, balls of microscopic blood vessels whose blood is infiltrated.
Finally, Pfizer and Moderna vaccines may also be responsible for the onset of nephrotic syndrome in vaccinated patients. This problem takes the form of swelling or edema of body tissues, with the risk of high blood pressure and red blood cells in the urine.
However, theEuropean Medicines Agency did not go into detail about the number of people involved in the study. To carry out its research, the Agency confirms that it has requested additional data from Pfizer and Moderna.
Vaccination in France: where do we stand Thursday July 13, 2023? Number of people vaccinated by region
How many people have received a first dose of covid-19 vaccine in France? Which regions are vaccinated the most? This Thursday July 13, 2023, we discover the number of people have received a first injection as well as those who are fully vaccinated in France since December 27, 2020. Click here to see the distribution of the number of people vaccinated or having received a booster dose by region. [Read more]